IC
RCUS icon

Ikarian Capital’s Arcus Biosciences RCUS Stock Holding History

Ikarian Capital’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-283,100
Closed -$5.85M – 131
2022
Q4 		$5.85M Buy
+283,100
New +$7.79M 1.41% 23
2022
Q3 		– Sell
-50,000
Closed -$1.27M – 152
2022
Q2 		$1.27M Buy
+50,000
New +$1.22M 0.23% 72
2022
Q1 		– Sell
-124,600
Closed -$5.04M – 208
2021
Q4 		$5.04M Buy
+124,600
New +$4.83M 0.75% 35
2021
Q3 		– Sell
-245,500
Closed -$6.74M – 247
2021
Q2 		$6.74M Hold
245,500
– – 0.55% 51
2021
Q1 		$6.89M Buy
245,500
+225,000
+1,098% +$7.83M 0.23% 95
2020
Q4 		$532K Buy
+20,500
New +$496K 0.02% 190

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Ikarian Capital's RCUS Position: Q2 2026 in Review

Ikarian Capital opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 504,559 shares worth $15.6M. The stake represents 1.68% of the portfolio and ranks #14 among its holdings. This is a return to the name: Ikarian Capital previously reported a position in RCUS as recently as Q2 2025.

Ikarian Capital first reported a position in RCUS in Q4 2022 and has held it in 10 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Ikarian Capital held 504,559 shares of Arcus Biosciences worth $15.6M as of Q2 2026.
  • Arcus Biosciences was a new Ikarian Capital position in Q2 2026.
  • Arcus Biosciences made up 1.68% of Ikarian Capital's portfolio in Q2 2026, its #14 holding.
  • Ikarian Capital first reported a position in Arcus Biosciences in Q4 2022 and has held it in 10 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.